Engineered botulinum neurotoxin
Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising one or more substitution mutations corresponding to substitution mutations in serotype B, strain 1, V1118M; Y1183M; E1191M; E1191I; E1191Q; E11...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
29.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!